This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Response to Commentary: “Using Questionnaires to Screen for Psychiatric Disorders.”

Robert M. A. Hirschfeld, Karen D. Wagner, Charles Holzer, Joseph R. Calabrese, Marilyn A. Davies, Myrna M. Weissman, Michael Reed, Mark A. Frye, Paul E. Keck, Jr., Susan L. McElroy and James McNulty

Published: May 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: While I appreciated the honesty of Lee and Fowler1 in revealing that their letter to the editor was supported by Eli Lilly and Company ("Funding for this letter was provided by Eli Lilly and Company"), I remain puzzled as to why and what it was that was funded by the pharmaceutical industry. Having written my share of letters to the editor (including this one),


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Assessment Methods , Diagnostic Tools

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...